DE69230881D1 - Corticotropinauslösefaktor-bindendes protein - Google Patents

Corticotropinauslösefaktor-bindendes protein

Info

Publication number
DE69230881D1
DE69230881D1 DE69230881T DE69230881T DE69230881D1 DE 69230881 D1 DE69230881 D1 DE 69230881D1 DE 69230881 T DE69230881 T DE 69230881T DE 69230881 T DE69230881 T DE 69230881T DE 69230881 D1 DE69230881 D1 DE 69230881D1
Authority
DE
Germany
Prior art keywords
crf
protein
proteins
residue
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69230881T
Other languages
English (en)
Other versions
DE69230881T2 (de
Inventor
Ellen Potter
Dominic P Behan
Wolfgang H Fischer
Elizabeth A Linton
Philip J Lowry
Wylie W Vale Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Reading
Salk Institute for Biological Studies
Original Assignee
University of Reading
Salk Institute for Biological Studies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Reading, Salk Institute for Biological Studies filed Critical University of Reading
Application granted granted Critical
Publication of DE69230881D1 publication Critical patent/DE69230881D1/de
Publication of DE69230881T2 publication Critical patent/DE69230881T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69230881T 1991-01-15 1992-01-13 Corticotropinauslösefaktor-bindendes protein Expired - Fee Related DE69230881T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64134191A 1991-01-15 1991-01-15
PCT/US1992/000331 WO1992013074A1 (en) 1991-01-15 1992-01-13 CORTICOTROPIN RELEASING FACTOR BINDING PROTEIN (CRF-bp)

Publications (2)

Publication Number Publication Date
DE69230881D1 true DE69230881D1 (de) 2000-05-11
DE69230881T2 DE69230881T2 (de) 2000-11-16

Family

ID=24571955

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69230881T Expired - Fee Related DE69230881T2 (de) 1991-01-15 1992-01-13 Corticotropinauslösefaktor-bindendes protein

Country Status (6)

Country Link
EP (1) EP0568622B1 (de)
JP (1) JP3090684B2 (de)
AT (1) ATE191502T1 (de)
CA (1) CA2097424A1 (de)
DE (1) DE69230881T2 (de)
WO (1) WO1992013074A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464757A (en) * 1991-01-15 1995-11-07 The Salk Institute For Biological Studies DNA encoding CRF binding protein
US5587462A (en) * 1993-11-08 1996-12-24 The Salk Institute For Biological Studies Brain-derived membrane-associated CRF binding proteins
US6039956A (en) * 1994-09-12 2000-03-21 Pennsylvania, Trustees Of The University Of, The Corticotropin release inhibiting factor and methods of using same for treating behavioral symptoms in an anxiety disorder
EP0781140A4 (de) * 1994-09-12 1999-11-03 Univ Pennsylvania Die corticotropinfreisetzung inhibierender faktor und verfahren zu seiner nutzung
CA2237548A1 (en) * 1995-11-14 1997-05-22 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Crf analogs and their use in photoaffinity labeling of crf receptors
JP5957443B2 (ja) * 2011-03-28 2016-07-27 長瀬産業株式会社 フェリチンの製造方法
WO2018132768A1 (en) * 2017-01-13 2018-07-19 Sanna Pietro P Methods and compositions for treating hpa hyperactivity
US11173992B2 (en) 2017-12-28 2021-11-16 Legionarus, Llc Buoyancy garment
US11471112B2 (en) 2018-11-21 2022-10-18 Legionarius, Llc Mobile application for wearable device
USD905935S1 (en) 2019-02-20 2020-12-29 Legionarius, Llc Shirt with back pocket

Also Published As

Publication number Publication date
ATE191502T1 (de) 2000-04-15
JPH06504445A (ja) 1994-05-26
DE69230881T2 (de) 2000-11-16
WO1992013074A1 (en) 1992-08-06
JP3090684B2 (ja) 2000-09-25
EP0568622B1 (de) 2000-04-05
EP0568622A1 (de) 1993-11-10
CA2097424A1 (en) 1992-07-15

Similar Documents

Publication Publication Date Title
DE69636764D1 (de) Zusammensetzungen zur behandlung von ischamischem gewebe
DK43890A (da) Nucleinsyre, vektorer og celler indeholdende den, derudfra fremstillede produkter og disses anvendelse
DE69230881D1 (de) Corticotropinauslösefaktor-bindendes protein
ATE141288T1 (de) Melaninkonzentrierende hormone und dns die diese expremieren
ATE337339T1 (de) Therapeutische verwendung von smr1 protein und seinen aktiven derivaten
JP2003534363A (ja) トランスジェニック非ヒト動物由来ヒト血清アルブミン含有化粧組成物
ATE297983T1 (de) Diagnose und behandlung von krankheiten mittels anti-t-zell rezeptor-vbeta-antikörper oder peptide, an denen diese antikörper spezifisch binden, und esrp1
DK0948536T3 (da) G-protein-koblet receptor med et forstörret extracellulært domæne
EA200300132A1 (ru) Стресс-белки и пептиды и способы их применения
PT914148E (pt) Tratamento do sindroma de insensibilidade parcial a hormona de crescimento
PT990000E (pt) Factor 3 de crescimento do tecido conjuntivo
KR950003312A (ko) 연골세포 단백질
Pivnik et al. Alteration of intraerythrocyte proteolytic degradation of hemoglobin during Hodgkin's disease
RU2614665C1 (ru) Способ стимуляции репаративного ангиогенеза и регенерации соединительной ткани, при её повреждении, методом генной терапии с использованием видоспецифичных генов белковых факторов vegf и fgf2, в ветеринарии, и генетическая конструкция для реализации заявленного способа
DE59208025D1 (de) Neue thrombininhibitorische proteine aus landblutegeln
DE69712182D1 (de) Peptide und ihre verwendung in der therapie von krankheiten des zöliakie-formenkreises
Bocci What are the roles of interferons in physiological conditions?
DE10311106B4 (de) Peptide gegen Kälteunverträglichkeit hervorrufende Autoantikörper, dafür kodierende Nukleinsäuren, ihre Verwendung und diese umfassende pharmazeutische Zusammensetzungen
Jahn et al. 65 LIVER MEMBRANE AUTOANTIBODIES (LMA) IN CHRONIC HEPATITIS OF THE AUTOIIMUNE TYPE: CHARACTERIZATION OF THE TARGET ANTIGEN.
Forsberg et al. Abdominal Fat Biopsy for Characterization of the Major Amyloid Fibril Proteins by Amino Acid Sequence Analysis
Marhaug et al. Characterization of serum amyloid A (SAA) protein in the sheep
Isachenkov et al. Immunoreactive luliberin in the visceral organs of rats
GB2259706B (en) Porcine adipocyte antigens and their use in the immunological control of fat
Murphy et al. Effects of olfactory bulb removal on brain norepinephrine in golden hamsters
WO2004011496A3 (en) Novel t-cell proteins, peptides and antibodies derived therefrom and uses thereof

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee